Jackson Michuda
Xalud Therapeutics (United States)(US)Foresite (United States)(US)Stanford University(US)
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Cancer Diagnosis and Treatment, SARS-CoV-2 and COVID-19 Research, DNA Repair Mechanisms, Head and Neck Cancer Studies
Most-Cited Works
- → Clinical validation of the tempus xT next-generation targeted oncology sequencing assay(2019)228 cited
- → Integrated genomic profiling expands clinical options for patients with cancer(2019)191 cited
- → Validation of genomic and transcriptomic models of homologous recombination deficiency in a real-world pan-cancer cohort(2022)55 cited
- → Disease diagnostics using machine learning of B cell and T cell receptor sequences(2025)55 cited
- → Validation of a Transcriptome-Based Assay for Classifying Cancers of Unknown Primary Origin(2023)37 cited
- → X-Atlas/Orion: Genome-wide Perturb-seq Datasets via a Scalable Fix-Cryopreserve Platform for Training Dose-Dependent Biological Foundation Models(2025)21 cited
- → Disease diagnostics using machine learning of immune receptors(2022)19 cited
- → Use of clinical RNA-sequencing in the detection of actionable fusions compared to DNA-sequencing alone.(2022)11 cited